Gestational Diabetes is a 2-part program. Your personal diabetes coach will guide you through a 4-month structured program that gives you the information and tools you need to successfully manage gestational diabetes. Then you'll receive 2 additional months of access to your coach so you can continue to ask questions and receive support after childbirth.
Thousands of people with type-2 diabetes in the UK are missing out on obesity surgery that would slash blood sugars and even lead to remission in some cases, a team of experts say. Leading surgeon Prof Francesco Rubino described the gut operation as "the closest thing to a cure" available. UK guidelines already recommend the surgery for some patients. But experts argue the guidance needs to be expanded and made more prominent, as most doctors do not offer it. About three million people in the UK have type-2 diabetes, which can lead to serious complications, including kidney failure, blindness and heart disease.
Delivering on what the company calls its vision to "transform care" for the millions currently living with diabetes through intelligent data, Medtronic has just announced new product developments and technology partnerships at the American Diabetes Association (ADA) 76th Scientific Sessions that will create "meaningful insights for providers and people with diabetes." New CareLink offerings and advancement of the Medtronic partnership with IBM Watson Health give doctors and their patients "more actionable information, enabling care that is more collaborative, consistent and effective." To boot, the company says, the growing network of Medtronic partnerships combines Medtronic diabetes expertise with capabilities expanding data usefulness to provide more holistic diabetes solutions. "Data, insights and analytics have been a cornerstone for our diabetes strategy with CareLink, and we have accumulated over 125 million patient days of data generated by our devices, including continuous glucose monitoring (CGM) sensor readings and insulin pump events," said Annette Brüls, president of Diabetes Service and Solutions at Medtronic. "Through our advanced CareLink portfolio and our expanded network of partnerships, we present actionable insights to drive holistic diabetes care solutions that offer greater freedom and better health to people with diabetes."
Verily, Google's former Life Sciences division, teamed up with a French pharmaceutical company to help treat diabetes just a few months ago. Now, it has joined forces with Nikon to enhance the screening process for diabetic retinopathy and macular edema -- diabetes-related eye diseases and two of the leading causes of blindness in adults. They want to create machine learning-enabled retinal imaging technologies that can detect the diseases in their early stages. That way, doctors can step in and prevent the patients from going blind whenever possible. The details of the partnership aren't entirely clear at this point, but Nikon will apparently use its expertise in "optical engineering and precision manufacturing, its proprietary ultra-widefield technology and strong commercial presence among eyecare specialists."
With the onslaught of hot flashes, night sweats and irritability, there's really never a time that women look forward to menopause. But new research published in the journal Diabetologia indicates that early menopause is associated with a higher risk of developing Type 2 diabetes. In a study of 3,639 women who did not initially have Type 2 diabetes, 348 developed the condition within a median time frame of nine years. Those who began menopause before 40 were nearly four times more likely to be diagnosed with the disease compared to women who were menopausal after 55. Once women reached 40 to 44 years old before starting menopause, their chances of developing diabetes was roughly two times higher.